E-Visit for COPD and Smoking Cessation

Pulmonary Disease, Chronic Obstructive Clinical Trial

Official title:

Development and Testing of an Electronic Visit for COPD Early Detection and Smoking Cessation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04155073
• Other study ID #: 00086016
• Status: Completed
• Phase: N/A
• Start date: December 12, 2019
• Est. completion date: March 12, 2021

Study information

• Verified date: July 2023
• Source: Medical University of South Carolina
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this work is to develop, refine, and pilot test an electronic visit (e-visit) to: 1) deliver smoking cessation treatment to adults at risk for COPD and 2) to improve rates of COPD early detection and accurate diagnosis. The investigators will conduct a pilot RCT of the COPD/smoking cessation e-visit as compared to treatment as usual (TAU), with primary objective to provide effect size estimates for a larger RCT.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 125
• Est. completion date: March 12, 2021
• Est. primary completion date: March 12, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• current cigarette smoker,

• enrolled in MUSC's Epic MyChart program or willing to sign up for MyChart,

• possess a valid e-mail address that is checked daily,

• English fluency, and

• owner of an iOS or Android-compatible smartphone and a webcam-enabled device

Exclusion Criteria:

• COPD on a patient's problem list within Epic.

Related Conditions & MeSH terms

• Cigarette Smoking
• Pulmonary Disease, Chronic Obstructive
• Telemedicine

Intervention

Behavioral:
• smoking cessation, early COPD detection, electronic visit
electronic visits (e-visits) for smoking cessation and early detection of chronic obstructive pulmonary disease (COPD)

Other:
• Treatment As Usual
Information about the state quitline and about the importance of quitting smoking and a recommendation to contact one's PCP to schedule a medical visit to discuss quitting smoking

Locations

Country	Name	City	State
United States	Medical University of South Carolina	Charleston	South Carolina

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evidence-based Cessation Treatment Utilization	participants in both groups will be queried for use of a smoking cessation medication since the last assessment	Baseline through Month 3
Primary	Number of Participants at Month 1 and Month 3 With At Least 1 Quit Attempt	quit attempts will be assessed at each follow-up using a timeline followback for the last 6-months at baseline and since prior follow-up for each subsequent assessment	Baseline through Month 3
Secondary	E-visit Acceptability and Feasibility	the percentage of patients who complete the initial and follow-up e-visits	Baseline through Month 3